Compagnie Lebon S.A. (ALBON.PA) stock: key figures, P/E, revenue and dividend
Financials · Asset Management & Custody Banks · France
Compagnie Lebon S.A. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 126.00 m EUR | 115.58 m EUR |
| Gross profit | 26.96 m EUR | 21.34 m EUR |
| Operating income | 3.31 m EUR | 15.11 m EUR |
| EBIT | 4.40 m EUR | 8.64 m EUR |
| Net income | -149,000.00 EUR | 4.10 m EUR |
| Diluted EPS – continuing operations | -0.13 EUR | 3.56 EUR |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Compagnie Lebon S.A.
Compagnie Lebon engages in the capital and real estate investment, asset management, hotel business, hydrotherapy, and heritage activities in France. The company is involved in the private equity business, which includes the acquisition of the majority and minority stakes in the capital of unlisted small and medium-sized companies; structuring and management of real estate club deals; and real estate valuation services. It also engages in the acquisition, renovation, management, and operation of boutique hotels; management of shops; leasing of office buildings; operation of parking spaces; investment management; direct investments in SMEs; real estate development and restructuring; and operation of thermal baths and spas under the Brides-les-Bains, Salins-les-Thermes, and Allevard names. The company was founded in 1835 and is headquartered in Paris, France. Compagnie Lebon operates as a subsidiary of France Participations SA.
More stocks
- EASY BIOInc (353810.KQ)
- Excelliance MOS (5299.TWO)
- Helixmith Co. Ltd (084990.KQ)
- Foghorn Therapeutics Inc. (FHTX)
- Lucara Diamond Corp (LUC.TO)
- MAXCYTE, INC. (MXCT)
- STLLR Gold Inc. (STLR.TO)
- WW INTERNATIONAL, INC. (WW)
- Jyong Biotech Ltd. Ordinary Shares (MENS)
- KLX Energy Services Holdings, Inc. (KLXE)
- Nykode Therapeutics ASA (NYKD.OL)
- K2 Gold Corporation (KTO.V)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.